Who owns the PROTRITAC trademark?

The PROTRITAC trademark is owned by Harpoon Therapeutics, Inc..

What is the serial number for PROTRITAC?

The USPTO serial number for PROTRITAC is 88168272.

What is the registration number for PROTRITAC?

PROTRITAC is registered under USPTO registration number 0.

PRO

USPTO Trademark Record

ABANDONED

PROTRITAC

Q: What class is the PROTRITAC trademark registered in?

The PROTRITAC trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 88168272·Reg 0·Filed Oct 24, 2018

Owner Harpoon Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

PROTRITAC (Serial No. 88168272), Registration No. 0, is a abandoned US trademark filed on Oct 24, 2018 by Harpoon Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

PROTRITAC (Reg. #0) is an abandoned US trademark that was filed in 2018 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 24, 2018

SERIAL

88168272

REG#

REGISTERED

Dec 31, 1969

Owner

Applicant

Harpoon Therapeutics, Inc.

Entity

Corporation

State

Address

4000 Shoreline Court, Suite 250, South San Francisco, CA, 94080

Country

Attorney

NameChristine K. Au-Yeung

Law firm

Christine K. Au-Yeung WILSON SONSINI GOODRICH & ROSATI

Docket

47517-TM1006

Address

650 PAGE MILL ROAD, PALO ALTO, CA 94304, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateOct 24, 2018

Serial Number88168272

Registration No.0

Registration DateDec 31, 1969

Status DateOct 03, 2022

Published for OppositionJul 02, 2019

Mark TypeStandard characters

Attorney Docket47517-TM1006

Status DescriptionDead and abandoned with no statement of use filed

Filing Signals

FILED

2018

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

39 events

ABANDONMENT - NO USE STATEMENT FILED

Oct 03, 2022

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Oct 03, 2022

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 10, 2022

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Feb 09, 2022

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 5 GRANTED

Feb 09, 2022

SOU EXTENSION 5 GRANTED

SOU TEAS EXTENSION RECEIVED

Feb 02, 2022

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 5 FILED

Feb 02, 2022

SOU EXTENSION 5 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 12, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Aug 10, 2021

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 4 FILED

Aug 10, 2021

SOU EXTENSION 4 FILED

SOU EXTENSION 4 GRANTED

Aug 10, 2021

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 04, 2021

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 3 GRANTED

Feb 02, 2021

SOU EXTENSION 3 GRANTED

SOU EXTENSION 3 FILED

Feb 02, 2021

SOU EXTENSION 3 FILED

SOU TEAS EXTENSION RECEIVED

Feb 02, 2021

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jul 22, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jul 20, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jul 20, 2020

SOU EXTENSION 2 FILED

SOU EXTENSION 2 GRANTED

Jul 20, 2020

SOU EXTENSION 2 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Jan 14, 2020

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Jan 10, 2020

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Jan 10, 2020

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Jan 10, 2020

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 27, 2019

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jul 02, 2019

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

PUBLISHED FOR OPPOSITION

Jul 02, 2019

PUBLISHED FOR OPPOSITION

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 12, 2019

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

May 29, 2019

ASSIGNED TO LIE

EXAMINERS AMENDMENT -WRITTEN

May 14, 2019

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

May 14, 2019

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

May 14, 2019

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

May 14, 2019

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 14, 2019

APPROVED FOR PUB - PRINCIPAL REGISTER

PRIORITY ACTION WRITTEN

Feb 07, 2019

PRIORITY ACTION WRITTEN

PRIORITY ACTION E-MAILED

Feb 07, 2019

PRIORITY ACTION E-MAILED

NOTIFICATION OF PRIORITY ACTION E-MAILED

Feb 07, 2019

NOTIFICATION OF PRIORITY ACTION E-MAILED

ASSIGNED TO EXAMINER

Jan 31, 2019

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 07, 2018

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 27, 2018

NEW APPLICATION ENTERED

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Recently filed and registered marks in the same international class.

PRO

PROTRITAC

97559351

Harpoon Therapeutics, Inc.

ABANDONED

PROTRITAC

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Harpoon Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Christine K. Au-Yeung

Resources

Company